NIH Program Announcements

  • Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21)
    (PA-17-103)
    National Institute of Mental Health
    Application Receipt/Submission Date(s): Standard AIDS dates apply , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
  • Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R01)
    (PA-17-104)
    National Institute of Mental Health
    Application Receipt/Submission Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on these dates.
  • Targeted basic behavioral and social science and intervention development for HIV prevention and care (R21)
    (PA-17-105)
    National Institute of Mental Health
    Application Receipt/Submission Date(s): Standard AIDS dates apply , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Targeted basic behavioral and social science and intervention development for HIV prevention and care (R01)
    (PA-17-106)
    National Institute of Mental Health
    Application Receipt/Submission Date(s): Standard AIDS dates apply by, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21)
    (PA-17-109)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01)
    (PA-17-110)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Neuroscience Research on Drug Abuse (R01)
    (PA-17-111)
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Neuroscience Research on Drug Abuse (R21)
    (PA-17-112)
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)
    (PA-17-113)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
    (PA-17-114)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): Standard AIDS dates apply , by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Chronic Condition Self-Management in Children and Adolescents (R01)
    (PA-17-115)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Chronic Condition Self-Management in Children and Adolescents (R21)
    (PA-17-116)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Reducing Health Disparities Among Minority and Underserved Children (R21)
    (PA-17-117)
    National Institute of Nursing Research
    National Institute on Deafness and Other Communication Disorders
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Reducing Health Disparities Among Minority and Underserved Children (R01)
    (PA-17-118)
    National Institute of Nursing Research
    National Institute on Deafness and Other Communication Disorders
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Basic Mechanisms of Brain Development Mediating Substance Use and Dependence (R01)
    (PA-17-119)
    National Institute on Drug Abuse
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01)
    (PA-17-120)
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42)
    (PAR-17-107)
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44)
    (PAR-17-108)
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • NIDA Core “Center of Excellence” Grant Program (P30)
    (PAR-17-121)
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): September 26, 2017; September 26, 2018, September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

NINDS Exploratory Clinical Trials (R01)
(PAR-17-122)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): March 21, 2017, then Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s